TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals
Curated by ChEMBL
Anacor Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: 1.96E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals
Curated by ChEMBL
Anacor Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: 3.05E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals
Curated by ChEMBL
Anacor Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: 3.95E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals
Curated by ChEMBL
Anacor Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: 8.28E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals
Curated by ChEMBL
Anacor Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: 9.70E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals
Curated by ChEMBL
Anacor Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: 1.05E+5nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals
Curated by ChEMBL
Anacor Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: 1.16E+5nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Anacor Pharmaceuticals
Curated by ChEMBL
Anacor Pharmaceuticals
Curated by ChEMBL
Affinity DataEC50: 1.37E+5nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair